Literature DB >> 10740130

Surrogate end points in cardiovascular disease trials.

T R Fleming1.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10740130     DOI: 10.1016/s0002-8703(00)90071-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy.

Authors:  Steven D Colan; Girish Shirali; Renee Margossian; Dianne Gallagher; Karen Altmann; Charles Canter; Shan Chen; Fraser Golding; Elizabeth Radojewski; Michael Camitta; Michael Carboni; Jack Rychik; Mario Stylianou; Lloyd Y Tani; Elif Seda Selamet Tierney; Yanli Wang; Lynn A Sleeper
Journal:  J Am Soc Echocardiogr       Date:  2012-06-05       Impact factor: 5.251

Review 2.  Triangulation of pharmacoepidemiology and laboratory science to tackle otic quinolone safety.

Authors:  Almut G Winterstein; Patrick J Antonelli
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-10-25       Impact factor: 3.688

3.  Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer.

Authors:  Saro H Armenian; Sarah K Gelehrter; Eric J Chow
Journal:  Cardiol Res Pract       Date:  2012-08-15       Impact factor: 1.866

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.